Artelo Total Stockholder Equity vs Property Plant And Equipment Net Analysis
| ARTL Stock | USD 1.11 0.02 1.77% |
Artelo Biosciences financial indicator trend analysis is way more than just evaluating Artelo Biosciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Artelo Biosciences is a good investment. Please check the relationship between Artelo Biosciences Total Stockholder Equity and its Property Plant And Equipment Net accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artelo Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.
Total Stockholder Equity vs Property Plant And Equipment Net
Total Stockholder Equity vs Property Plant And Equipment Net Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Artelo Biosciences Total Stockholder Equity account and Property Plant And Equipment Net. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Artelo Biosciences' Total Stockholder Equity and Property Plant And Equipment Net is 0.82. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Property Plant And Equipment Net in the same time period over historical financial statements of Artelo Biosciences, assuming nothing else is changed. The correlation between historical values of Artelo Biosciences' Total Stockholder Equity and Property Plant And Equipment Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Artelo Biosciences are associated (or correlated) with its Property Plant And Equipment Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant And Equipment Net has no effect on the direction of Total Stockholder Equity i.e., Artelo Biosciences' Total Stockholder Equity and Property Plant And Equipment Net go up and down completely randomly.
Correlation Coefficient | 0.82 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Most indicators from Artelo Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Artelo Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artelo Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.The value of Selling General Administrative is expected to slide to about 2.3 M. The value of Issuance Of Capital Stock is estimated to slide to about 538.6 K
Artelo Biosciences fundamental ratios Correlations
Click cells to compare fundamentals
Artelo Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Artelo Biosciences fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 6.5M | 4.4M | 12.6M | 20.4M | 13.0M | 13.7M | |
| Total Stockholder Equity | 5.5M | 3.9M | 12.0M | 19.4M | 11.8M | 12.3M | |
| Net Tangible Assets | (135.0K) | 3.4M | 1.8M | 10.0M | 11.5M | 12.1M | |
| Net Debt | (4.4M) | (2.1M) | (6.5M) | (6.8M) | (6.1M) | (5.8M) | |
| Retained Earnings | (4.8M) | (9.5M) | (16.9M) | (31.0M) | (40.3M) | (38.3M) | |
| Cash | 4.4M | 2.1M | 6.6M | 6.9M | 2.8M | 2.6M | |
| Cash And Short Term Investments | 4.4M | 2.1M | 10.1M | 17.5M | 20.2M | 21.2M | |
| Common Stock Total Equity | 11.3K | 14.0K | 3.4K | 5.0K | 4.5K | 6.3K | |
| Common Stock Shares Outstanding | 144.8K | 247.2K | 1.2M | 2.8M | 3.2M | 3.3M | |
| Liabilities And Stockholders Equity | 6.5M | 4.4M | 12.6M | 20.4M | 23.5M | 24.7M | |
| Other Stockholder Equity | 10.3M | 13.3M | 28.9M | 50.7M | 58.3M | 61.2M | |
| Total Liab | 1.0M | 502.2K | 593K | 1.0M | 1.3M | 1.4M | |
| Total Current Assets | 4.4M | 2.3M | 10.3M | 18.3M | 11.0M | 11.5M | |
| Common Stock | 3.4K | 5.0K | 25K | 3K | 3.5K | 3.3K | |
| Other Current Liab | 323.8K | (478.3K) | (488K) | (852K) | (766.8K) | (728.5K) | |
| Total Current Liabilities | 1.0M | 502.2K | 526K | 998K | 1.3M | 1.4M | |
| Accounts Payable | 348.9K | 490.2K | 493K | 905K | 1.2M | 1.3M | |
| Other Current Assets | 18.6K | 195.1K | 252K | 789K | 554K | 581.7K | |
| Accumulated Other Comprehensive Income | (9.8K) | 63.8K | 18K | (254K) | (228.6K) | (217.2K) | |
| Property Plant Equipment | 563.0 | 721.0 | 246.0 | 90K | 103.5K | 108.7K | |
| Non Current Assets Total | 2.0M | 2.0M | 2.3M | 2.1M | 2.1M | 1.5M | |
| Non Currrent Assets Other | 563.0 | 2.0M | 189K | 3K | 3.5K | 3.3K | |
| Non Current Liabilities Total | 529.3K | 348.9K | 490.2K | 67K | 23K | 0.0 | |
| Net Invested Capital | 5.5M | 3.9M | 12.0M | 11.8M | 13.5M | 7.1M | |
| Net Working Capital | 3.4M | 1.8M | 9.8M | 9.7M | 11.1M | 11.7M | |
| Property Plant And Equipment Net | 721.0 | 246.0 | 90K | 60K | 21K | 31.6K | |
| Property Plant And Equipment Gross | 721.0 | 246.0 | 90K | 21K | 24.2K | 24.5K | |
| Capital Stock | 3.4K | 5.0K | 25K | 3K | 2.7K | 2.6K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artelo Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Artelo Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.87) | Return On Assets (0.54) | Return On Equity (0.89) |
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Artelo Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Artelo Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Artelo Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.